Kintor Pharmaceutical Limited
HKEX:9939.HK
Overview | Financials
Company Name | Kintor Pharmaceutical Limited |
Symbol | 9939.HK |
Currency | HKD |
Price | 0.91 |
Market Cap | 399,852,371 |
Dividend Yield | 0% |
52-week-range | 0.79 - 3.6 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Youzhi Tong |
Website | https://www.kintor.com.cn |
An error occurred while fetching data.
About Kintor Pharmaceutical Limited
Kintor Pharmaceutical Limited, a clinical-stage biotechnology company, engages in developing and commercializing a pipeline of small molecule and biological therapeutics for androgen-receptor-related disease areas with unmet medical needs in the People's Republic of China and internationally. The company's products pipeline include Proxalutamide, a second generation androgen receptor (AR) antagonist for
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD